TY - JOUR T1 - Fevers Are Rarest in the Morning: Could We Be Missing Infectious Disease Cases by Screening for Fever Then? JF - medRxiv DO - 10.1101/2020.05.23.20093484 SP - 2020.05.23.20093484 AU - Charles Harding AU - Francesco Pompei AU - Samantha F Bordonaro AU - Daniel C McGillicuddy AU - Dmitriy Burmistrov AU - Leon D Sanchez Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/26/2020.05.23.20093484.abstract N2 - Body temperatures are less likely to reach the fever range in the morning,1,2 but it is unknown how this affects practice during disease outbreaks. We retrospectively investigated fever-range temperatures (≥100.4°F, ≥38.0°C) during seasonal influenza outbreaks and the 2009 H1N1 (swine flu) pandemic, which have recently been used as preparatory models for coronavirus disease 2019 (COVID-19). Our analyses included a nationally representative sample of records from adult visits to US emergency departments (n=202,181) and data from a Boston emergency department (n=93,225). Fever-range temperatures were about half as common in the morning as in the evening, suggesting that morning temperatures can be much less diagnostic, and that revisions may be needed to the practice of once-daily temperature screens at morning arrival to workplaces and schools. Twice-daily screens could be a simple solution, but similar research is still needed on fevers in COVID-19 itself.Competing Interest StatementExergen, Corp. (Watertown, MA) provided thermometers (temporal artery, model TAT-5000), technical support and funding, including funding for CH and DB's participation. FP is CEO and founder of Exergen and holds patents related to the devices under study. There are no other funding sources or conflicts of interest to disclose for this report or the originating studies.Funding StatementExergen, Corp. (Watertown, MA) provided thermometers (temporal artery, model TAT-5000), technical support and funding, including funding for CH and DB's participation. There are no other funding sources to disclose for this report or the originating studies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board of Beth Israel Deaconess Medical Center approved the Boston emergency department study (2008-P-000412).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized datasets from the National Hospital Ambulatory Medical Care Surveys (NHAMCS) are publicly available from the National Center for Health Statistics of the U.S. Centers for Disease Control and Prevention. Data from the Boston study may be available from the authors upon reasonable request, subject to privacy restrictions. https://www.cdc.gov/nchs/ahcd/datasets_documentation_related.htm ER -